These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1080 related items for PubMed ID: 25406148

  • 1. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
    Ho CW, Ho MH, Chan PH, Hai JJ, Cheung E, Yeung CY, Lau KK, Chan KH, Lau CP, Lip GY, Leung GK, Tse HF, Siu CW.
    Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
    [Abstract] [Full Text] [Related]

  • 2. Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation.
    Chan PH, Huang D, Hai JJ, Li WH, Yin LX, Chan EW, Wong IC, Lau CP, Chiang CE, Zhu J, Tse HF, Siu CW.
    Heart Rhythm; 2016 Feb; 13(2):366-73. PubMed ID: 26392326
    [Abstract] [Full Text] [Related]

  • 3. Intensity and quality of warfarin anticoagulation in Chinese patients: setting the record straight.
    Eikelboom JW, Hart RG.
    Stroke; 2015 Jan; 46(1):5-6. PubMed ID: 25406147
    [No Abstract] [Full Text] [Related]

  • 4. Response to letter regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".
    Chan PH, Hai JJ, Siu CW.
    Stroke; 2015 Mar; 46(3):e72. PubMed ID: 25649808
    [No Abstract] [Full Text] [Related]

  • 5. Letter by Feng et al regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".
    Feng X, Huan Y, Lv Y.
    Stroke; 2015 Mar; 46(3):e71. PubMed ID: 25649800
    [No Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP.
    Ann Intern Med; 2011 Jan 04; 154(1):1-11. PubMed ID: 21041570
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ, Reichman ME, Wernecke M, Zhang R, Southworth MR, Levenson M, Sheu TC, Mott K, Goulding MR, Houstoun M, MaCurdy TE, Worrall C, Kelman JA.
    Circulation; 2015 Jan 13; 131(2):157-64. PubMed ID: 25359164
    [Abstract] [Full Text] [Related]

  • 8. Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA2DS2-VASc and Time in Therapeutic Range.
    Chan PH, Huang D, Lau CP, Chan EW, Wong IC, Lip GY, Tse HF, Siu CW.
    Can J Cardiol; 2016 Oct 13; 32(10):1247.e15-1247.e21. PubMed ID: 27118057
    [Abstract] [Full Text] [Related]

  • 9. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.
    Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, Ezekowitz MD, Yusuf S.
    Stroke; 2012 Jun 13; 43(6):1511-7. PubMed ID: 22492518
    [Abstract] [Full Text] [Related]

  • 10. Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications.
    Albert NM.
    Heart Lung; 2014 Jun 13; 43(1):48-59. PubMed ID: 24373340
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack.
    Kamel H, Johnston SC, Easton JD, Kim AS.
    Stroke; 2012 Mar 13; 43(3):881-3. PubMed ID: 22308255
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project.
    Li WH, Huang D, Chiang CE, Lau CP, Tse HF, Chan EW, Wong ICK, Lip GYH, Chan PH, Siu CW.
    Clin Cardiol; 2017 Apr 13; 40(4):222-229. PubMed ID: 27893153
    [Abstract] [Full Text] [Related]

  • 13. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F, Renlund H, Lip GY, Wester P, Svensson PJ, Själander A.
    JAMA Cardiol; 2016 May 01; 1(2):172-80. PubMed ID: 27437888
    [Abstract] [Full Text] [Related]

  • 14. Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran.
    Vaughan Sarrazin MS, Jones M, Mazur A, Chrischilles E, Cram P.
    Am J Med; 2014 Dec 01; 127(12):1179-85. PubMed ID: 25107386
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.
    Chevalier J, Delaitre O, Hammès F, de Pouvourville G.
    Arch Cardiovasc Dis; 2014 Dec 01; 107(6-7):381-90. PubMed ID: 24973113
    [Abstract] [Full Text] [Related]

  • 16. Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study.
    Lehto M, Luojus A, Halminen O, Haukka J, Putaala J, Linna M, Mustonen P, Kinnunen J, Lehtonen O, Teppo K, Tiili P, Kouki E, Itäinen-Strömberg S, Niemi M, Aro AL, Hartikainen J, Airaksinen KEJ, FinACAF Study Group.
    Ann Med; 2024 Dec 01; 56(1):2364825. PubMed ID: 38873855
    [Abstract] [Full Text] [Related]

  • 17. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):567-74. PubMed ID: 23922182
    [Abstract] [Full Text] [Related]

  • 18. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.
    J Am Coll Cardiol; 2013 Dec 10; 62(23):2199-204. PubMed ID: 24055744
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of three methods of antithrombotic therapy in elderly patients with nonvalvular atrial fibrillation].
    Shevelev VI, Kanorskiĭ SG.
    Kardiologiia; 2012 Dec 10; 52(7):56-60. PubMed ID: 22839715
    [Abstract] [Full Text] [Related]

  • 20. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.
    Banerjee A, Lane DA, Torp-Pedersen C, Lip GY.
    Thromb Haemost; 2012 Mar 10; 107(3):584-9. PubMed ID: 22186961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.